hedge fund
Allergan shareholders reject proposal to split roles of chairman and CEO
May 2, 2019Research and Development Allergan, Appaloosa, CEO, board of directors, hedge fund, pharma
Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, both of which are currently …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
